BRIEF published on 04/07/2026 at 07:05, 6 months 8 days ago Aelis Farma obtient une subvention de 458 000 € pour son programme de lutte contre l'obésité France 2030 Aelis Farma Récepteur CB1 Recherche Sur L'obésité Subvention De Nouvelle-Aquitaine
BRIEF published on 04/07/2026 at 07:05, 6 months 8 days ago Aelis Farma Secures €458k Grant for Obesity Program France 2030 Aelis Farma Obesity Research CB1 Receptor Nouvelle-Aquitaine Grant
PRESS RELEASE published on 04/07/2026 at 07:00, 6 months 8 days ago Informations privilégiées / Autres communiqués Aelis Farma reçoit 458 k€ de subvention de France 2030 en Nouvelle-Aquitaine pour son programme innovant dans l'obésité et les maladies métaboliques. Soutien non dilutif pour la recherche sur les traitements des désordres métaboliques Subvention France 2030 Obésité Aelis Farma Nouvelle-Aquitaine
PRESS RELEASE published on 04/07/2026 at 07:00, 6 months 8 days ago Inside Information / Other news releases Aelis Farma receives €458k grant under France 2030 for obesity program development, reinforcing innovation potential in metabolism field Metabolic Diseases Grant France 2030 Obesity Aelis Farma
BRIEF published on 03/21/2026 at 10:10, 6 months 25 days ago Aelis Farma Advances Phase 2B Clinical Trial for Down Syndrome Treatment Clinical Trial CB1 Receptor AEF0217 Down Syndrome Adaptive Behavior
BRIEF published on 03/21/2026 at 10:10, 6 months 25 days ago Aelis Farma fait progresser son essai clinique de phase 2B pour le traitement du syndrome de Down Essai Clinique AEF0217 Syndrome De Down Récepteur CB1 Comportement Adaptatif
PRESS RELEASE published on 03/21/2026 at 10:05, 6 months 25 days ago Informations privilégiées / Autres communiqués Aelis Farma lance avec succès l'étude clinique de Phase 2B avec AEF0217 pour traiter les troubles comportementaux et cognitifs du syndrome de Down. Recrutement actif en France, Italie et Espagne Phase 2b Étude Clinique Aelis Farma AEF0217 Syndrome De Down
PRESS RELEASE published on 03/21/2026 at 10:05, 6 months 25 days ago Inside Information / Other news releases Aelis Farma initiates Phase 2B clinical trial with AEF0217 for Down syndrome cognitive impairments, recruiting in France, Italy, and Spain. A promising first-in-class CB1-SSi inhibitor treatment Phase 2b Aelis Farma AEF0217 Down Syndrome Cognitive Impairments
BRIEF published on 01/12/2026 at 07:35, 9 months 3 days ago Aelis Farma obtient un avis favorable de l'EMA pour AEF0217 dans la trisomie 21 EMA Aelis Farma Trisomie 21 AEF0217 Développement Pédiatrique
BRIEF published on 01/12/2026 at 07:35, 9 months 3 days ago Aelis Farma receives a favorable opinion from the EMA for AEF0217 in trisomy 21 EMA Aelis Farma AEF0217 Down Syndrome Pediatric Development
Published on 10/15/2026 at 19:25, 2 hours 43 minutes ago Datavault AI Highlights Data Futures Platform Patent Amid Tokenized Stock Exemption
Published on 10/15/2026 at 16:10, 5 hours 58 minutes ago North Shore Announces Extension to Falcon Property Option Agreement and Resource Stock Digest Engagement
Published on 10/15/2026 at 15:15, 6 hours 53 minutes ago Gold Terra to Host Community Town Hall Meeting in Yellowknife on October 21, 2026
Published on 10/15/2026 at 14:31, 7 hours 37 minutes ago First Breach to Present at the 20th Annual LD Micro Main Event
Published on 10/15/2026 at 14:05, 8 hours 3 minutes ago Innodata to Report Third Quarter 2026 Results
Published on 10/15/2026 at 20:30, 1 hour 38 minutes ago Nordex Group reports strong preliminary Q3/2026 results and raises EBITDA margin guidance for full year 2026
Published on 10/15/2026 at 20:28, 1 hour 39 minutes ago EQS-Adhoc: Nordex SE: Nordex Group reports strong preliminary Q3/2026 results and raises EBITDA margin guidance for full year 2026
Published on 10/15/2026 at 18:03, 4 hours 5 minutes ago AIXTRON Q3 2026: Order intake and operating profitability significantly exceed market expectations
Published on 10/15/2026 at 18:00, 4 hours 8 minutes ago BOA Concept Group étoffe son offre et intègre les AMR KUKA
Published on 10/15/2026 at 18:50, 3 hours 18 minutes ago September & first 9 months of 2026 traffic figures - Revision of Traffic assumptions for 2026
Published on 10/15/2026 at 18:50, 3 hours 18 minutes ago Trafic du mois de septembre et des 9 premiers mois de l'année 2026 - Révision des hypothèses de trafic pour l'année 2026
Published on 10/15/2026 at 18:16, 3 hours 51 minutes ago Déclaration des droits de vote au 30 septembre 2026
Published on 10/15/2026 at 18:14, 3 hours 53 minutes ago Déclaration des droits de vote au 31 août 2026
